Piperlongumine-inhibited TRIM14 signaling sensitizes glioblastoma cells to temozolomide treatment

Immunology and Microbiology

• RNA Sequence 100%
• Cytotoxicity 100%
• Epithelial Mesenchymal Transition 100%
• Cell Viability 100%
• Cell Invasion 100%
• Glioblastoma Multiforme Cell Line 100%
• Transcriptomics 100%
• Piper Longum 100%
• Cell Growth 100%
• Astrocyte 100%
• Apoptosis 100%

Biochemistry, Genetics and Molecular Biology

• P38 Mitogen-Activated Protein Kinases 100%
• Apoptosis 50%
• Cell Invasion 50%
• Anticancer 50%
• Mesenchymal-Epithelial Transition 50%
• Cell Viability 50%
• RNA Sequence 50%
• Transcriptomics 50%
• Gene Analysis 50%
• Piper Longum 50%
• Cell Growth 50%
• Cytotoxicity 50%
• Astrocyte 50%
• Gene Set Enrichment Analysis 50%

Medicine and Dentistry

• Glioblastoma 100%
• Temozolomide 100%
• Neoplasm 20%
• Cancer 20%
• p38 Mitogen-Activated Protein Kinase 20%
• Programmed Cell Death 10%
• Cell Growth 10%
• RNA Sequence 10%
• Cell Invasion 10%
• Cell Viability 10%
• Antiinfective Agent 10%
• Ganglioglioma 10%
• Mesenchymal-Epithelial Transition 10%
• Gene Set Enrichment 10%
• Glioblastoma Multiforme Cell Line 10%
• Transcriptomics 10%
• The Cancer Genome Atlas 10%
• Astrocyte 10%
• Cytotoxicity 10%